CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 30 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 388,632 | $2,048,000 | 1.16% |
Tri Locum Partners LP | 522,943 | $2,756,000 | 1.10% |
Sio Capital Management, LLC | 422,598 | $2,227,000 | 0.71% |
Affinity Asset Advisors, LLC | 400,000 | $2,108,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $2,679,000 | 0.22% |
Ikarian Capital, LLC | 99,422 | $524,000 | 0.04% |
PURA VIDA INVESTMENTS, LLC | 105,141 | $554,000 | 0.02% |
Virtu Financial LLC | 20,029 | $106,000 | 0.01% |
NEXT Financial Group, Inc | 14,752 | $77,000 | 0.01% |
Schonfeld Strategic Advisors LLC | 103,925 | $548,000 | 0.01% |